Skip to main content
NeopharmCO.,LTD. logo

NeopharmCO.,LTD. — Investor Relations & Filings

Ticker · 092730 ISIN · KR7092730001 KO Manufacturing
Open in API
Filings indexed 205 across all filing types
Latest filing 2019-05-24 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 092730

About NeopharmCO.,LTD.

https://neopharm.co.kr

Neopharm is a science-based company specializing in the development, manufacturing, and sale of dermatological skincare and cosmetic products. A pioneer in skin barrier research, the company focuses on restoring skin homeostasis. Its core innovation is the proprietary Multi-Lamellar Emulsion (MLE) technology, which mimics the natural lipid structure of the skin to repair and strengthen its protective functions. The company's primary product lines, including the flagship brand Atopalm, are specifically formulated for sensitive, dry, and compromised skin. These non-steroid solutions are grounded in dermatological science to address various skin concerns.

Recent filings

Filing Released Lang Actions
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Services Commission and Korea Exchange, specifically detailing a 'Decision on Paid-in Capital Increase' (유상증자결정). It outlines the number of new shares, issuance price, purpose of funds (operating capital), and third-party allocation details. This falls under the category of share issuance and capital changes.
2019-05-24 Korean
분기보고서 (2019.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for NeoPharm for the first quarter of 2019 (January 1, 2019, to March 31, 2019). It contains detailed financial information, business descriptions, and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2019
2019-05-10 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) for Neopharm, detailing quarterly financial highlights such as revenue, operating profit, and net income for the period ending 2019-03-31. It is a short, structured announcement of financial results rather than a full quarterly report or a report publication announcement. Therefore, it fits the definition of an Earnings Release (ER). Q1 2019
2019-05-03 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a regulatory filing required when an entity's shareholding in a listed company crosses a specific threshold (typically 5%). The document details the reporting entity (KB Asset Management), the issuer (NeoPharm), and provides a comprehensive log of share transactions (acquisitions and disposals) over a specific period. This fits the definition of a 'Major Shareholding Notification' (MRQ).
2019-05-02 Korean
소속부변경
Regulatory Filings Classification · 95% confidence The document is a short, structured announcement regarding a change in the company's market classification (from 'Venture' to 'Blue Chip' status) on the stock exchange. It does not contain financial statements, proxy materials, or management reports, but rather serves as a regulatory notification of a corporate status change. As it does not fit into specific categories like M&A, dividends, or director dealings, it falls under the general regulatory filing category.
2019-04-30 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed by the National Pension Service of Korea regarding their stake in Neopharm. This type of filing is a regulatory requirement for entities that cross specific ownership thresholds in a publicly traded company. In the context of financial reporting classifications, this falls under 'Major Shareholding Notification'.
2019-04-02 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.